Tenon Medical Analyst Price Targets

Wall Street analyst price targets and consensus rating for Tenon Medical (TNON).

Price Target Range — 4 Quarters

Analyst Consensus — 2 Analysts

2Buy

Consensus RatingBuy# Analysts2Avg. Consensus PT$408Upside to Avg. PT+20733.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Apr 9, 2025	Alliance Global Partners	Scott Henry	Initiate	Buy	$105
Nov 15, 2024	Maxim Group	Anthony Vendetti	PT Cut	Buy	$770→$280
Aug 14, 2024	Benchmark	Bruce Jackson	Maintained	Speculative Buy	$840
Apr 15, 2024	Benchmark	Bruce Jackson	PT Cut	Speculative Buy	$1400→$840

Analyst Ratings News

PRO
Alliance Global Partners Initiates Coverage On Tenon Medical with Buy Rating, Announces Price Target of $3

Alliance Global Partners analyst Scott Henry initiates coverage on Tenon Medical (NASDAQ:TNON) with a Buy rating and announces Price Target of $3.

Benzinga Newsdesk

US Stocks Likely To Open Higher After Monday's Selloff: TSLA Stock Rebounds From Its Worst Fall In 5 Years After Trump Backs Musk, Analyst Says 'Pullbacks Are Normal'

U.S. stock futures rose on Tuesday following Monday's heavy selloff. Futures of all four benchmark indices surged in premarket trading.

Rishabh Mishra

PRO
Benchmark Reiterates Speculative Buy on Tenon Medical, Maintains $3 Price Target

Benchmark analyst Bruce Jackson reiterates Tenon Medical (NASDAQ:TNON) with a Speculative Buy and maintains $3 price target.

Benzinga Newsdesk

PRO
Benchmark Maintains Speculative Buy on Tenon Medical, Lowers Price Target to $3

Benchmark analyst Bruce Jackson maintains Tenon Medical (NASDAQ:TNON) with a Speculative Buy and lowers the price target from $5 to $3.

Benzinga Newsdesk

PRO
Benchmark Reiterates Buy on Tenon Medical, Maintains $6 Price Target

Benchmark analyst Jackson Ader reiterates Tenon Medical (NASDAQ:TNON) with a Buy and maintains $6 price target.

Benzinga Newsdesk

Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2022

Upgrades

Benzinga Insights

Tenon Medical Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Tenon Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Alliance Global Partners Initiates Coverage On Tenon Medical with Buy Rating, Announces Price Target of $3

US Stocks Likely To Open Higher After Monday's Selloff: TSLA Stock Rebounds From Its Worst Fall In 5 Years After Trump Backs Musk, Analyst Says 'Pullbacks Are Normal'

PRO
Benchmark Reiterates Speculative Buy on Tenon Medical, Maintains $3 Price Target

PRO
Benchmark Maintains Speculative Buy on Tenon Medical, Lowers Price Target to $3

PRO
Benchmark Reiterates Buy on Tenon Medical, Maintains $6 Price Target

Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2022

People Also Watch

People Also Watch

Tenon Medical Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Tenon Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROAlliance Global Partners Initiates Coverage On Tenon Medical with Buy Rating, Announces Price Target of $3

US Stocks Likely To Open Higher After Monday's Selloff: TSLA Stock Rebounds From Its Worst Fall In 5 Years After Trump Backs Musk, Analyst Says 'Pullbacks Are Normal'

PROBenchmark Reiterates Speculative Buy on Tenon Medical, Maintains $3 Price Target

PROBenchmark Maintains Speculative Buy on Tenon Medical, Lowers Price Target to $3

PROBenchmark Reiterates Buy on Tenon Medical, Maintains $6 Price Target

Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2022

People Also Watch

People Also Watch

PRO
Alliance Global Partners Initiates Coverage On Tenon Medical with Buy Rating, Announces Price Target of $3

PRO
Benchmark Reiterates Speculative Buy on Tenon Medical, Maintains $3 Price Target

PRO
Benchmark Maintains Speculative Buy on Tenon Medical, Lowers Price Target to $3

PRO
Benchmark Reiterates Buy on Tenon Medical, Maintains $6 Price Target